Zilbrysq - bulk
Ended Awarded Last action
- Contract number
- 36C26025F0033
- Awardee
-
Ucb, Inc. UEI F3N9Q9TY2BC9
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $214,215
Award facts
- Contract value 100% obligated
- $214,214.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$155,885 | |
| Original award | $370,100 |
About this award
UCB Pharma, Inc. (also operating as Ucb, Inc.) has been awarded a delivery order valued at $214,214.58 by the Department of Veterans Affairs through Veterans Integrated Service Network 20 for the supply of Zilbrysq in bulk. The contract, issued on October 25, 2024, is a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and will be performed in Pittsburgh, Pennsylvania. This award is not designated as a set-aside contract and is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a General Services Administration master schedule that provides the VA with pre-negotiated pricing for pharmaceutical products.
This delivery order is issued against UCB Pharma's existing Federal Supply Schedule contract with the VA, which carries a ceiling value of $1.11 billion and extends through September 2030. UCB Pharma, a global biopharmaceutical company specializing in neurology and immunology treatments, maintains an ongoing supply relationship with the VA for multiple critical prescription medications. The company has established a substantial track record delivering pharmaceutical products to the VA system, with this latest award continuing the supply of Zilbrysq, an important therapeutic medication for veterans within the VA healthcare network.
Quick answers
Who was awarded contract 36C26025F0033?
36C26025F0033 was awarded to Ucb, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 25, 2024.
How much is contract 36C26025F0033 worth?
The government has obligated $214,215 on 36C26025F0033.
Is contract 36C26025F0033 an order under another contract?
Yes. 36C26025F0033 is a delivery order under 36F79719D0247, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26025F0033 competed?
The extent of competition for 36C26025F0033 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award